The company was founded in 2013, by Ambika Bump, and Terry Sachlos with the aim of the introduction of revolutionary Nanodiamond based technology, especially for earlier detection of cancer diseases. The company is located in Berkeley, California
Bikanta is biotech; the company mainly focuses on developing clinical products that led to earlier detection of cancer by inserting fluorescent Nanodiamond. The possibility of nanotechnology in the near term is to act as a tool to study disease. These Nanodiamonds are capable of detecting any abnormal molecular activities at much higher rates, thus enables doctors to stop cancer from spreading any further.
Some of the Bikanta’s product categories are:
Bikanta’s key partners are Oxbridge Biotech Roundtable, Molecular Foundry, and QB3, etc. Its main competitors are TeraSense, Neaspec, TeraView, Asqella, INO, and Tracer.